Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Code

Type your Poster Code, then hit apply

Showing 1,267 results.

Thumbnail for Suicide Mortality Among Hematological Malignancy Survivors: A Population-Based SEER-CDC analysis

AML - 350

Suicide Mortality Among Hematological Malignancy Survivors: A Population-Based SEER-CDC analysis

Vidushi Reddy Gillela

Poster Presenter: Vidushi Reddy Gillela

Thumbnail for Therapy-Related Myeloid Neoplasms After Radioactive Iodine in Thyroid Cancer: A Scoping Review

AML - 357

Therapy-Related Myeloid Neoplasms After Radioactive Iodine in Thyroid Cancer: A Scoping Review

Tareq Abuasab

Poster Presenter: Tareq Abuasab

Thumbnail for Mortality Trends and Disparities Due to Acute Myeloid Leukemia Coexisting With Agranulocytosis: A 26-Year CDC WONDER Analysis From 1999 to 2024

Previous 1...34 35 36 37 38 39 40...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

AML - 372

Mortality Trends and Disparities Due to Acute Myeloid Leukemia Coexisting With Agranulocytosis: A 26-Year CDC WONDER Analysis From 1999 to 2024

Fnu Sumia

Poster Presenter: Fnu Sumia

Thumbnail for Lineage-Specific CK2a Deletion Reshapes the Transcriptome of Hematopoietic Stem Cells Toward an Immune-Primed State

AML - 377

Lineage-Specific CK2a Deletion Reshapes the Transcriptome of Hematopoietic Stem Cells Toward an Immune-Primed State

Yasin Uzun

Poster Presenter: Yasin Uzun

Thumbnail for Venetoclax in Combination With a Hypomethylating Agent for Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Medically Unfit for Intensive Induction Therapy: A Real-World Community Experience

AML - 384

Venetoclax in Combination With a Hypomethylating Agent for Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Medically Unfit for Intensive Induction Therapy: A Real-World Community Experience

Chiara Perni

Poster Presenter: Chiara Perni

Thumbnail for Rural-Urban Disparities in Leukemia Mortality Trends Among Young Adults Aged 15-34: A CDC Wonder Analysis (1999-2024)

AML - 398

Rural-Urban Disparities in Leukemia Mortality Trends Among Young Adults Aged 15-34: A CDC Wonder Analysis (1999-2024)

Madho Mal

Poster Presenter: Madho Mal

Thumbnail for Declining but Unequal: Trends and Sociodemographic Disparities in Acute Myeloid Leukemia Mortality in the United States, 2018-2024

AML - 402

Declining but Unequal: Trends and Sociodemographic Disparities in Acute Myeloid Leukemia Mortality in the United States, 2018-2024

Priscilla Kabutey

Poster Presenter: Priscilla Kabutey

Thumbnail for Early vs Late Granulocyte Colony-Stimulating Factor Initiation and Hospital Length of Stay in Adult Inpatients With Severe Neutropenia: A Retrospective Cohort Study

AML - 409

Early vs Late Granulocyte Colony-Stimulating Factor Initiation and Hospital Length of Stay in Adult Inpatients With Severe Neutropenia: A Retrospective Cohort Study

Ramyar Abdullah

Poster Presenter: Ramyar Abdullah

$Thumbnail for Menin Inhibitors vs FLT3 Inhibitor-Based Therapy in NPM1-Mutated Relapsed/Refractory AML: Comparative Efficacy, MRD Depth, and Safety Profiles$

AML - 414

Menin Inhibitors vs FLT3 Inhibitor-Based Therapy in NPM1-Mutated Relapsed/Refractory AML: Comparative Efficacy, MRD Depth, and Safety Profiles

Hashem Haj Ebrahimi

Poster Presenter: Hashem Haj Ebrahimi

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors